Clinical Trials in Ohio

Showing 16361-16380 of 20,938 trials

Dose-Dense Docetaxel Before or After Doxorubicin/Cyclophosphamide in Axillary Node-Positive Breast Cancer

NCT00201708

This study will determine if docetaxel will be administered before or after doxorubicin/cyclophosphamides in an adjuvant chemotherapy regimen to be evaluated in a subsequent phase III trial.

Breast Cancer

Ohio State University Comprehensive Cancer Center56 participantsStarted Oct 2004

Columbus, Ohio, United States

COMPLETEDPhase 332 miles

Efficacy and Safety of Empagliflozin (BI 10773) With Metformin in Patients With Type 2 Diabetes

NCT01167881

This is a pivotal phase III study, mandatory to seek approval by regulatory authorities for BI 10773 as an anti-diabetic agent compared to an active comparator in patients with type 2 diabetes mellitus and insufficient glycaemic control.

Diabetes Mellitus, Type 2

Boehringer Ingelheim1,549 participantsStarted Aug 2010

Phoenix, Arizona, United States • Phoenix, Arizona, United States • Hot Springs, Arkansas, United States +179 more locations

Dose-Dense Docetaxel Before or After Doxorubicin/Cyclophosphamide in Axillary Node-Positive Breast Cancer

Efficacy and Safety of Empagliflozin (BI 10773) With Metformin in Patients With Type 2 Diabetes

Find Trials by Condition in Ohio

Sensor Optimization of Cardiac Resynchronization Therapy Response

Bipolar Study in Adults at Least 18 Years of Age

Study of the Safety and Local Tolerability of Intranasal Gel Formulations of XF-73

Discovery and Validation of Proteogenomic Biomarker Panels in Liver Transplant Recipients

Radiation Therapy and Temozolomide Followed by Temozolomide Plus Sorafenib for Glioblastoma Multiforme

Study to Assess the Safety, Tolerability, and Pharmacokinetics of AMP-224 in Patients With Advanced Cancer

Assessment of the Safety, Tolerability and Efficacy of MEDI8968 in Subjects With Moderate to Severe Hidradenitis Suppurativa

Clinical Decision Rule Validation Study to Predict Low Recurrent Risk in Patients With Unprovoked Venous Thromboembolism

Outpatient Pump Shutoff Pilot Feasibility and Efficacy Study

Outpatient Reduction of Nocturnal Hypoglycemia by Using Predictive Algorithms and Pump Suspension in Children

Neoadjuvant Sunitinib With Paclitaxel/Carboplatin in Patients With Triple-Negative Breast Cancer

A Study of Vemurafenib (RO5185426) in Participants With Metastatic or Unresectable Papillary Thyroid Cancer Positive for the BRAF V600 Mutation

Efficacy and Safety of BI 201335 (Faldaprevir) in Combination With Pegylated Interferon-alpha and Ribavirin in Treatment-Experienced Genotype 1 Hepatitis C Infected Patients (STARTverso 3)

Robotic-assisted Versus Laparoscopic Sigmoid Resection

Phase I Safety Study of the Drug MM-121 in Patients With Advanced Solid Tumors Resisting Ordinary Treatment

Pharmacokinetic Study of CYCLOSET ® 0.8 mg Tablets in Children and Adolescent Type 2 Diabetes Mellitus Subjects

Hormone Responses During Hypoglycemia and the Accuracy of Continuous Glucose Monitors

Study of Efficacy and Safety INC280 in Patients With Advanced Hepatocellular Carcinoma